ask="3.20"
ask_size="200"
average_daily_volume="223210"
bid="2.80"
bid_size="500"
book_value="0.07"
change="+0.05"
change_from_200_day_moving_average="0.03"
change_from_50_day_moving_average="0.34"
change_from_52_week_high="-1.35"
change_From_52_week_low="0.75"
change_in_percent="+1.61%"
close="3.15"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.98"
ebitda="-30.33M"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-1.10"
ex_dividend_date="N/A"
float_shares="26690000"
high="3.15"
high_52_weeks="4.50"
last_trade_date="2/21/2017"
last_trade_price="3.15"
last_trade_size="4154"
last_trade_time="4:00pm"
low="3.10"
low_52_weeks="2.40"
market_capitalization="142.80M"
moving_average_200_day="3.12"
moving_average_50_day="2.81"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="3.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+1.06%"
percent_change_from_50_day_moving_average="+12.26%"
percent_change_from_52_week_high="-30.00%"
percent_change_from_52_week_low="+31.25%"
previous_close="3.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="43.06"
price_per_sales="11.11"
revenue="12.65M"
shares_outstanding="45333000"
short_ratio="17.80"
stock_exchange="NGM"
symbol="ACRX"
volume="139778"
weeks_range_52="2.40 - 4.50"
